Last reviewed · How we verify

NCT04544917

SmartManage Stress Management for HIV+ Cancer Survivors

Completed NA Last updated 13 August 2025
What this trial tests

NA trial testing SmartManage for HIV+ cancer survivors in Cancer in 32 participants. Completed in 3 September 2024.

Timeline
15 February 2021
Primary endpoint
3 September 2024
3 September 2024

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment32
Start date15 February 2021
Primary completion3 September 2024
Estimated completion3 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, male only, with Cancer or Hiv. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04544917.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing